-Congratulations!-Recently, I had the opportunity to participate in some great Unicity events in both Frankfurt and Zurich. The power, motivation, and excitement demonstrated at these meetings was truly inspirational and motivating. These events have made me want to do a little more, be a little better, and spend a little more effort doing the things I know will make me successful. Thank you to many of you who participated and made these events so successful!
As we reflect over the last few months, there is no doubt that this is a great time to be with Unicity! In October, Unicity Europe experienced another outstanding month. Recruiting in October jumped by over 50%! This was mainly due to our recent introduction of the Bios Life® CSM program. In fact, since first introducing this unique program, sales have increased by almost 23%, with Germany and Switzerland leading the way. We continue to work hard to expand this program into our many other languages and countries in Europe so all partners can benefit from this proven system.
More importantly, more and more people are experiencing the personal benefits of what the Bios Life® CSM can do for themselves and others. Those who are following the program are reporting that they are experiencing better health, more energy, increased self-confidence, and a more fulfilled life. As one partner recently told me, the "Bios Life® CSM program has given me a new perspective on life and what I know I can accomplish." Additionally, many partners are realizing the financial stability that comes with building a business with the Bios Life® CSM. Recently, another partner said, the "Bios Life® CSM program, combined with the new Compensation Plan, has made presenting the business much simpler, more enjoyable, and more exciting as I watch my income steadily increase each month."
As we continue to share the Bios Life® CSM opportunity, and build our business, it is important to remember these words - “Success first requires expending ten units of effort to produce one unit of results. Your momentum will then produce ten units of results with each unit of effort.”
I wish each of you great success as we continue to build this exciting business. LET’S KEEP THE MOMENTUM GOING!
Robert Cluff
General Manager, Europe
NEW COMPENSATION PLAN,
EFFECTIVE OCTOBER 1, 2012:Attention! Don’t forget about the exciting enhancements to the compensation plan – increase your income and enhance your business now!BIOS LIFE® CSM FLYER: The Bios Life® CSM flyers are available to download now from the franchise office.
Click to see photos.
SWITZERLAND EVENT
Click to see photos.MAKE LIFE BETTER REWARDS TRIP,
MARCH 13-17, 2013
Click to See Video
CLICK TO SEE QUALIFICATION
English Italiano FrançaisNederlands Svenska
Friday, November 30, 2012
BIOS LIFE CSM PRE LAUNCH IN EUROPE
Sunday, November 25, 2012
FDA Warns on Statin Drugs Labels on Popular Cholesterol Medicines Must Cite Risk of Diabetes, Memory Loss
FDA Warns on Statin Drugs Labels on Popular Cholesterol Medicines Must Cite Risk of Diabetes, Memory Loss
by Nora Effendi on Thursday, 30 August 2012 at 11:10 ·
The Food and Drug Administration warned that patients taking cholesterol-fighting statins face a small increase in the risk of higher blood-sugar levels and of being diagnosed with diabetes, raising concerns about one of the country's most widely prescribed groups of drugs.
The federal safety agency said Tuesday it plans to require drug makers to add the diabetes-risk language to the "warnings and precautions" section of the labels on statin drugs.
Statins include top-selling brand names such as Lipitor, Crestor, Zocor and a dozen or so other branded and generic versions under various names. The drugs are prescribed to more than 20 million Americans a year, at a cost of more than $14 billion in 2011, according to the research firm IMS Health.
The warning isn't expected to prompt doctors to stop prescribing statins for patients with multiple risk factors for heart attack. Cardiologists said for many patients, the benefits of statins still outweigh these risks.
The diabetes issue is "real" but "not a huge effect," said Robert Califf, vice chancellor for clinical research and a cardiologist at Duke University Medical Center. "Informing people is a good thing, but for the vast majority of people who really need to be on a statin, this shouldn't change what they do."
But some physicians cautioned that the risk wasn't insignificant and that patients at lower risk for heart problems might want to reassess whether they should remain on statins.
"The diabetes issue is a really big deal. We're overcooking the statin use," said Eric J. Topol, a prominent cardiologist and chief academic officer of Scripps Health in LaJolla, Calif.
More
Amy Egan, the FDA's deputy director for safety of metabolic and endocrinological products, said "these cognitive changes can be quite dramatic" and "sustained" but that they disappear when statin therapy is stopped. Dr. Egan said the agency cannot identify a specific drug or age group of people who might be prone to such cases. She said patients should notify their doctors if these symptoms occur.
Enlarge Image
Bloomberg News
Cholesterol drugs Lipitor and Zocor are arranged on a counter of a Cambridge, Massachusetts pharmacy in 2006.
The FDA made new labeling recommendations for one specific statin, Mevacor, generically called lovastatin. It said that some medicines like protease drugs used to treat AIDS and drugs for bacterial and fungal infections shouldn't be taken with Mevacor because of interactions that may lead to muscle injury.
At the same time, the FDA announced that drug makers could remove a label warning that liver enzymes need to be monitored during statin therapy. It cited the fact that "serious liver injury with statins is rare and unpredictable" and that periodic monitoring "does not appear to be effective in detecting or preventing this rare side effect."
AstraZeneca AZN +0.02% PLC, which makes Crestor, the only major statin still sold exclusively as a brand-name drug, said in a statement that "the cognitive issues are generally nonserious and reversible upon discontinuation" of a statin. It said reports about increased blood sugar were already included on Crestor labels.
In addition to the pure statins, products that contain statins include Advicor, Simcor and Vytorin. Merck & Co., which makes Zocor and Vytorin, said information for those drugs was "updated" in October in a way that reflects the contents of the FDA's Tuesday safety advisory. It revised labeling for Mevacor more recently.
The FDA's action follows analyses of large numbers of statin studies in recent years. In one, published in the Lancet in 2010, researchers looked at 13 studies including 91,140 patients. The researchers concluded that statin therapy "is associated with a slightly increased risk of development of [Type 2] diabetes, but the risk is low both in absolute terms and when compared to the reduction in coronary events."
Cardiologists differed on how to weigh the findings, especially for the millions of people given the drugs for the prevention of a first heart attack or stroke.
Steven E. Nissen, chairman of cardiovascular medicine at the Cleveland Clinic, said, "There is no question that statins slightly increase the risk of a diabetes diagnosis and of slightly higher blood sugar, but I think this has no impact on the risk-benefit assessment. I know I can lower the [relative] risk of death, stroke and heart attack by about 30%" in patients at high risk of such cardiovascular events.
Dr. Topol said research suggests that for every 200 people who take a statin, 1 will develop diabetes. By comparison, 1 to 2 out of 100 patients at risk for a heart attack will avoid one, he said, adding, "That's a very narrow margin of benefit," he said.
Rita Redberg, a cardiologist at the University of California, San Francisco Medical Center, stressed the long-term concerns about diabetes. "We know that diabetes is a significant risk factor for heart disease," Dr. Redberg said. She said the statin-diabetes link "raises the concern that over time the diabetes risk will outweigh the cholesterol-lowering benefit on overall risk of cardiovascular disease."
The federal safety agency said Tuesday it plans to require drug makers to add the diabetes-risk language to the "warnings and precautions" section of the labels on statin drugs.
Statins include top-selling brand names such as Lipitor, Crestor, Zocor and a dozen or so other branded and generic versions under various names. The drugs are prescribed to more than 20 million Americans a year, at a cost of more than $14 billion in 2011, according to the research firm IMS Health.
Cholesterol drugs Lipitor and Zocor
The warning isn't expected to prompt doctors to stop prescribing statins for patients with multiple risk factors for heart attack. Cardiologists said for many patients, the benefits of statins still outweigh these risks.
The diabetes issue is "real" but "not a huge effect," said Robert Califf, vice chancellor for clinical research and a cardiologist at Duke University Medical Center. "Informing people is a good thing, but for the vast majority of people who really need to be on a statin, this shouldn't change what they do."
But some physicians cautioned that the risk wasn't insignificant and that patients at lower risk for heart problems might want to reassess whether they should remain on statins.
"The diabetes issue is a really big deal. We're overcooking the statin use," said Eric J. Topol, a prominent cardiologist and chief academic officer of Scripps Health in LaJolla, Calif.
More
- Are Statins Worth the Risk?
Amy Egan, the FDA's deputy director for safety of metabolic and endocrinological products, said "these cognitive changes can be quite dramatic" and "sustained" but that they disappear when statin therapy is stopped. Dr. Egan said the agency cannot identify a specific drug or age group of people who might be prone to such cases. She said patients should notify their doctors if these symptoms occur.
Enlarge Image
Bloomberg News
Cholesterol drugs Lipitor and Zocor are arranged on a counter of a Cambridge, Massachusetts pharmacy in 2006.
The FDA made new labeling recommendations for one specific statin, Mevacor, generically called lovastatin. It said that some medicines like protease drugs used to treat AIDS and drugs for bacterial and fungal infections shouldn't be taken with Mevacor because of interactions that may lead to muscle injury.
At the same time, the FDA announced that drug makers could remove a label warning that liver enzymes need to be monitored during statin therapy. It cited the fact that "serious liver injury with statins is rare and unpredictable" and that periodic monitoring "does not appear to be effective in detecting or preventing this rare side effect."
AstraZeneca AZN +0.02% PLC, which makes Crestor, the only major statin still sold exclusively as a brand-name drug, said in a statement that "the cognitive issues are generally nonserious and reversible upon discontinuation" of a statin. It said reports about increased blood sugar were already included on Crestor labels.
In addition to the pure statins, products that contain statins include Advicor, Simcor and Vytorin. Merck & Co., which makes Zocor and Vytorin, said information for those drugs was "updated" in October in a way that reflects the contents of the FDA's Tuesday safety advisory. It revised labeling for Mevacor more recently.
The FDA's action follows analyses of large numbers of statin studies in recent years. In one, published in the Lancet in 2010, researchers looked at 13 studies including 91,140 patients. The researchers concluded that statin therapy "is associated with a slightly increased risk of development of [Type 2] diabetes, but the risk is low both in absolute terms and when compared to the reduction in coronary events."
Cardiologists differed on how to weigh the findings, especially for the millions of people given the drugs for the prevention of a first heart attack or stroke.
Steven E. Nissen, chairman of cardiovascular medicine at the Cleveland Clinic, said, "There is no question that statins slightly increase the risk of a diabetes diagnosis and of slightly higher blood sugar, but I think this has no impact on the risk-benefit assessment. I know I can lower the [relative] risk of death, stroke and heart attack by about 30%" in patients at high risk of such cardiovascular events.
Dr. Topol said research suggests that for every 200 people who take a statin, 1 will develop diabetes. By comparison, 1 to 2 out of 100 patients at risk for a heart attack will avoid one, he said, adding, "That's a very narrow margin of benefit," he said.
Rita Redberg, a cardiologist at the University of California, San Francisco Medical Center, stressed the long-term concerns about diabetes. "We know that diabetes is a significant risk factor for heart disease," Dr. Redberg said. She said the statin-diabetes link "raises the concern that over time the diabetes risk will outweigh the cholesterol-lowering benefit on overall risk of cardiovascular disease."
Sunday, November 18, 2012
Reverse Diabetes, Obesity ,Heart Disease, & IBS Naturally
more details...
Simple to use, and 100% safe, even for children, BiosLife Slim has drastically improved the quality of life for thousands and provides highly effective glycemic control at meals which makes fat loss consistent and dramatic.
Doctors are finding such improvements in diabetic patients and in the treatment of cardiovascular disease as their patients use BiosLife Slim seeing cholesterol levels, both HDL & LDL, are improved quickly as well as triglycerides, that the need for medications are greatly reduced or become unnecessary as symptoms improve,naturally.
Though thousands of Doctors and medical professionals use Bios Life in their practices, it is a non prescription, natural supplement available to the public. Whether you're under doctor supervision or not, BiosLife Slim will help you make phenomenal improvements in your health and your physical appearance, simply, without risk, side effects, or interference with medication. The marked results of people using Bioslife Slim for obesity makes it a real, safe and preferable alternative to lap band, weight loss surgery, gastric bypass and other costly, painful, risky treatments allowing for a normal life without the long term effects of such radical procedures. If you are considering such drastic measures, do yourself a favor and try Slim first, it's absolutely guaranteed to work or its free.
BiosLife Slim and Slim-G are advanced formulations that are multi-patented, nothing comparable out there, that work in six ways to give you unparalleled results and control by blocking the damaging ingredients, namely sugar/glucose from foods, particularly those that have addictive qualities so difficult to resist. By removing the sugar overload using Slim daily, you allow internal healing and more optimal function resulting in internal health improvements that create the desirable physical visual changes as well as longevity and health benefits.
BiosLife is clinically proven by the Cleveland Clinic, Johns Hopkins, Stanford Medical, and other prestigious medical groups proving its performance, listed in the Physicians Desk Reference Learn what makes BiosLife Slim so different from anything in prescription or other single solution in this 18 minute video.
If you want to know more information about products just contact
RAJUREDDY
@ MR_RAJUREDDY@LIVE.com,
Join in MedScape Project and make your life better:))))
Escape from medicine with BiosLife Slim
What Is Bios Life Slim...?
- Bios Life Slim is a revolutionary fat burning product;
- providing the first scientific breakthrough in fat-loss in over 30 years.
- Containing natural, proprietary ingredients,
- Bios Life Slim helps your body naturally regulate the amount of fat stored.
- Not only does it aid in fat loss,
- but it naturally reduces cholesterol and helps balance your blood sugar.
30 minutes - Young India faces heart attack - Part 1 - Tv9
I am on a mission to make life better with bioslife:)))))
30 minutes - Young India faces heart attack - Part 3 - Tv9
Young India faces heart attack.
Guys becare full with your health:))))))
Make life better with bioslife S
Young India suffers from heart disease - Tv9
Indian youngsters aged 30 and above are falling prey to cardi -- vascular disease. The reasons are stress, bad dietary habits and lack of exercise. Earlier one would only think of heart disease in people aged 40 and above but now young people are also reporting symptoms of heart disease. The situation is alarming.
Thursday, November 15, 2012
Tuesday, November 13, 2012
HAPPY DEEPAVALI
Every year deepavali coming and going nothing specials in life but this year with god blessing we have an opportunity to do something in our life, we can make our life better.
HAPPY DEEPAVALI TO ALL MY DISTRIBUTORS, MAY THE FESTIVAL OF LIGHTS BRING GOOD HEALTH, WEALTH, HAPPINESS AND JOY TO YOU AND YOUR FAMILY.
Regards,
ShyamSunder Reddy and team
Sunday, November 11, 2012
World Diabetes Day special
On this episode we throw light on why diabetes should not be taken lightly
Diabetes, hypertension cases on the rise in India
Life in the fast lane, fuelled by fast food and typical every day urban habits are your worst enemy. A new study by pharma company Sanofi, done on 16,000 people across eight states finds that one in five Indian adults in the metros suffers from both diabetes and hypertension.
Diabetes explosion in India
Be care full guys diabetes is very dangerous disease it may cause so many problem if you take continous taking medication try to avoid medicine go for diet and excercise.
If you want to more infirmation just contact shyam@9866342733,kitto2127@gmail.com
Regards,
sagar
Make life better
Prevent Heart Attack
The Cholesterol Care Company educates people about the risks associated with elevated cholesterol and offer effective lifestyle changes and natural solutions that do not involve statin drugs with their list of dangerous side effects.
Saturday, November 10, 2012
Phuket - Paradise Island
Exciting holiday trip guys try to reach our target as soon as possible we will meet up at thailand phuket!!!!!!!!!!!!
THAILAND PHUKET TRIP
Guys get ready for beutiful phuket thailand trip!!!!!!!!!!!!!!!!!!
Fired up:)
go diamond
PHUKET Rewards trip is easier NOW hurry up!!!!!!
Dear Unicity Distributor,
We are pleased to inform you that the qualification criteria for the next Rewards Trip to the exotic destination of PHUKET is now easier, simpler. Please go thru the qualification requirements below and feel free to contact your immediate up line or your up line leader or customer care at 1800 102 2467.
UNICITY INDIA | ||||
PHUKET Rewards Trip - Apr'13 | ||||
Period Oct '12 - feb'13 | ||||
Rank | OV requirement | Rule | For 2 Tkts | |
Dist - Sr Manager | 20,000 | 40% outside largest leg | 30,000 OV | |
Director | 25,000 | 40% outside largest leg | 37,500 OV | |
SD | 40,000 | 40% outside largest leg | 60,000 OV | |
ED | 1,00,000 | 40% outside largest leg | 1,25,000 OV | |
PD and above | 1,50,000 | 40% outside largest leg | 1,50,000 OV | |
For all Ranks from Distributor to Diamond to qualify for the trip, apart from the above requirement, they will have to Sponsor or Enroll a minimum of 6 distributors during the qualifying period of Oct'12 - Feb'13 each joining at min 100 PV. | ||||
Rules: | ||||
NEW COMPENSATION PLAN
Dear Unicity Distributor,
We are pleased to announce the changes to the Career Compensation Plan basis feedback from the Leaders. We believe the changes will benefit the Unicity distributors to build their business better and earn more incomes.
Please note the below changes which will be effective November 2012 commission month. The highlights of the plan changes are:
· TV has been reduced from 500 to 200 TV
· Fast Start Bonus will be paid on the first month purchase of the new distributor instead of joining month
· FSB - Level 1 will be paid, Distributor 5%, Jr. Manager 10% Manager 25%
· FSB - Level 2 will be paid, Distributor/Jr. Manager/Manager - 3% each
· Sr Manager and Director ranks are included or FSB
· FSB – Sr. Manager up to Diamond will be paid 3% each.
· Director lifestyle bonus is renamed as TBB ( Team Builder Bonus)
· TBB Rule – Advance to and maintain a rank for 2 out of 3 consecutive months.
· Sr. Manager – 25,000 INR for 2 months achievement.
· Director – 90,000 INR for 2 months achievement.
· Sr. Director – 1,25,000 INR for 2 months achievement.
· Ex. Director – 2,00,000 INR for 2 months achievement.
· Personal Rebate - 5% up to 499 PV ; 30% 500 PV & above
· Rank Maintenance Bonus
ü Director – 10,000 INR for 12 months
ü Sr. Director – 15,000 INR for 12 months
ü Ex. Director – 20,000 INR for 12 months
· Sr Manager rank requirement – min 2 legs @ 500 OV, 40% OV to come from outside the largest leg.
Dear friends this is a wonderful opportunity to us we have to rock on!!!!!
fired up:)
sagar
Wednesday, November 7, 2012
Monday, November 5, 2012
Don't Be a Wage Slave! Be your Own Boss!
Today's Reality........Recessions and Retrenchments !
Don't Be A Wage Slave ! Be your Own Boss !
Unicity, our Dream Vehicle, now has a GPS, to take you wherever you want to go.
...
Don't Be A Wage Slave ! Be your Own Boss !
Unicity, our Dream Vehicle, now has a GPS, to take you wherever you want to go.
...
Come to explore your New Possibilities with us.
Come to find out how you can achieve The 100% Happy Life - when you will have financial freedom, time freedom and optimal health to enjoy the Life Of Your Dreams - the Ultimate Lifestyle!
Meet the success stories of the Unipower system and learn from them
first-hand how you too can achieve The 100% Happy Life, in 3-5 years.
Call Shyam @ 00919866342733 or email to kitto2127@gmail.com to fix an appt for a friendly discussion
To find out more on how to achieve Time/Health/Financial freedom, please visit http://cmteamunicity.blogspot.co.uk
Come to find out how you can achieve The 100% Happy Life - when you will have financial freedom, time freedom and optimal health to enjoy the Life Of Your Dreams - the Ultimate Lifestyle!
Meet the success stories of the Unipower system and learn from them
first-hand how you too can achieve The 100% Happy Life, in 3-5 years.
Call Shyam @ 00919866342733 or email to kitto2127@gmail.com to fix an appt for a friendly discussion
To find out more on how to achieve Time/Health/Financial freedom, please visit http://cmteamunicity.blogspot.co.uk
Thailand mid-year convention of 2012
Thailand is a small country they sent a message to the world, showcasing 11 lamboghinis as the highest symbol of success earned by their leaders what a shame of our country,India is a big country how many Lamboghinis we have to get it??? Come on friends wake up we have a wonderful opportunity to success in our life.
Fired up:)
Go diamond
Saturday, November 3, 2012
Bios life D
Diabetes Research on Bios Life®
According to the American Heart Association, some 17 million Americans are afflicted with diabetes, and that number grows rapidly as sedentary lifestyles and convenience-oriented eating habits prevail. Today pharmacy shelves are well stocked with insulin, insulin sensitizers, and glucose desensitizers, all of which play an important role in managing this widespread disease.However, long-term use of these costly medications can cause a range of harmful conditions including insulin resistance, liver dysfunction, and edema. Even with the assistance of medication, most diabetics will eventually succumb to complications of the disease, such as blindness, nerve damage, and kidney failure.
But recent clinical studies and scientific reviews point to a safe, powerful, natural product that can help patients control blood glucose levels-a key to long-term management of diabetes. Bios Life® is clinically proven to help improve glycemic control, decrease hyperinsulinemia, and lower plasma lipid concentration in patients with Type 2 Diabetes.1 This approach can serve as an effective adjunct and an eventual replacement for prescription medication.
Bios Life® is a natural formulation that protects the body from the damage that can be caused by glucose and insulin spikes by delaying gastric emptying and lowering postprandial blood sugar.2 Simply put, when patients take Bios Life® shortly before a meal, it creates a gel fiber matrix in the stomach. As the gel moves through the intestinal tract, food gets trapped inside it for short periods of time.
This lowers the rate at which food is absorbed, thereby extending the time over which blood-sugar levels rise and fall. With this more gradual process, the average blood-sugar level remains lower throughout the day, stabilizing both blood glucose and insulin at a healthy and acceptable plateau.
Bios Life® is easy to use and safe for long-term usage. It's simple to incorporate into a daily routine, which can lead to higher compliance. Each serving contains a patented, scientifically-formulated matrix of fibers, vitamins, and anti-oxidants which the body needs daily.
References:
- Freed, S. H.; Joffe, D .J. "The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes." Diabetes in Control, Issue 15 (1): 12-18 2000 Aug
- Bell, D. S. "Importance of postprandial glucose control." South Med J. 2001 Aug; 94(8):804-9
Bios Life® proved effective in a clinical trial conducted by Independent Certified Diabetes Educators working with Diabetes in Control.com that was presented at the 2001 American Association of Certified Diabetes Educators (AADE) conference.
Results from Fiber Supplementation Study
Summary:This independent group studied diabetic patients for three months and gave them Bios Life® twice daily before meals.
- Average reduction in postprandial 3 blood glucose of 17.2 percent
- Average reduction of fasting blood glucose of 17 percent
- Average reduction of total cholesterol of 17 percent
- Average reduction of HbA1c of 15.2% in the 1st three months of usage. (HbA1c is an indicator of average blood sugar levels.)
- Average drop in blood pressure of 5 percent
- Average drop in body weight of 4 percent (8 pounds)
- Average drop in triglycerides of 42 percent
- Average increase in HDL cholesterol of 6 percent
When the vascular endpoints are averaged, the study shows an overall reduction in macro vascular endpoints of 18 percent. And it shows an overall reduction of micro vascular endpoints of 17 percent.
To access a copy of this study, go to http://www.diabetesincontrol.com/studies/fiber.shtml
Success Stories From People Like You For eleven years, I have struggled with diabetes. I have had seven eye surgeries, have lost my left eye, and have diminished vision in my right eye due to diabetic retinopathy. In July of last year, I was taking 220 units of insulin a day. I had gained 50 pounds and still had blood sugar levels running from 190 to 390. My doctor took me off insulin and started me on maximum doses of Glucophage and Amaryl. After several months, he told me these drugs were not working. I was scared.
Meanwhile my business partner told me about a nonprescription, natural product that was helping other people control their blood sugar levels. At this point, what did I have to lose? I took a packet of BiosLife2 and a list of ingredients to my endocrinologist. He said, "There is nothing in this that can hurt you." On January 9th I started taking Rx for Life (containing Bios Life® 2) while on Amaryl and Glucophage with no insulin. In less than one week, my blood sugar was 153, in two weeks under 100 and have had blood sugar readings of less than 80. I reduced the Glucophage by 2/3 and Amaryl to 1/2 of the original dose So far, I have lost 32 pounds. My last examination by my eye surgeon showed no new leakage and no new bleeding in my eyes. I am saving the vision I have left. I needed a miracle and I thank God for guiding me to this.
Dick B. When I started taking BiosLife2 on the recommendation of my physician in February, my weight was 225 and my fasting blood sugar readings were 220 to 240, and that was while taking 58 units of insulin in the morning and 48 in the evening. As of April my weight is 202 (a 23 pound loss) and my fasting blood sugar readings are now 76 to 95. I only take 20 units of Insulin in the morning and 15 in the evening to maintain those readings. Best of all, I don't have to starve myself to do this. Unicity saved my life.
H. Ralph S.
In July I became ill and was admitted to our local hospital. It was discovered that I was a severe diabetic. At that time my blood sugar level was 314 before my evening meal and 569 directly after. My cholesterol was 259 and my triglycerides were 429. I was given an impossible diet and released from the hospital ten days later. My medication included Proventil by inhaler for my asthmatic condition, Seldane for allergies and the insulin which I gave myself by injection two or three times daily.
Then a miracle happened to me. My nephew introduced me to the RX for Life Program (BiosLife). Within two weeks I was able to reduce my insulin intake by half and kept reducing it for the following three months until my doctor said, "Congratulations, your blood sugar level is normal!" But that's not all. My cholesterol fell to 186 (73 point drop) and my triglycerides fell to 183 (246 point drop). I no longer use the Proventil or the Seldane and instead I take Defend-Ol and Calmplex2000 daily and Reliev-Ol as needed. I have lost over 50 pounds. Thank God for Rexall
Subscribe to:
Posts (Atom)